Plantarc Bio (Israel) Top Management

Plantarc Bio Management Team Effectiveness

The company has return on total asset (ROA) of (0.1751) % which means that it has lost $0.1751 on every $100 spent on assets. This is way below average. Similarly, it shows a return on equity (ROE) of (0.2971) %, meaning that it generated substantial loss on money invested by shareholders. Plantarc Bio's management efficiency ratios could be used to measure how well Plantarc Bio manages its routine affairs as well as how well it operates its assets and liabilities. The market capitalization of Plantarc Bio is 28.91 Million. Plantarc Bio has significant amount of outstanding shares owned by insiders. An insider is usually defined as a CEO, other corporate executive, director, or institutional investor who own at least 10% of the company's outstanding shares. Since such a large part of the company is owned by insiders, it is advisable to analyze if each of these insiders have been buying or selling the stock in recent months. Note, that even with negative profits, if the true value of the company is larger than the current market value, you may still be able to generate positive returns on investment in this company. Some institutional investors establish a significant position in stocks such as Plantarc Bio in order to find ways to drive up its value. Retail investors, on the other hand, need to know that institutional holders can own millions of shares of Plantarc Bio, and when they decide to sell, the stock will often sell-off, which may instantly impact shareholders' value. So, traders who get in early or near the beginning of the institutional investor's buying cycle could potentially generate profits.

Plantarc Bio Workforce Comparison

Plantarc Bio Notable Stakeholders

String symbol = request.getParameter("s");

The success or failure of an entity such as Plantarc Bio often depends on how effective the management is. Plantarc Bio management team is responsible for propelling the future growth in the right direction and administering and controlling the business activities and accounting for the results. Ineffective management usually contributes to failure in the company's future performance for all stakeholders equally, but most importantly, for investors. So it is important to measure the effectiveness of Plantarc management before purchasing its stock. In many ways, it's all about finding the answer to one important question - Are they doing the right thing right now? How would we assess whether the Plantarc management is utilizing all available resources in the best possible way? Also, how well is the company doing relative to others in its sector and the market as a whole? The answer can be found by analyzing a few important fundamental indicators such as return on assets and return on equity.

Please note, the presentation of Plantarc Bio's financial position, as portrayed in its financial statements, is often influenced by management's estimates, judgments, and sometimes even manipulations. In the best case, Plantarc Bio's management is honest, while the outside auditors are strict and uncompromising. Please utilize our Beneish M Score to check the likelihood of Plantarc Bio's management manipulating its earnings.

When running Plantarc Bio's price analysis, check to measure Plantarc Bio's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Plantarc Bio is operating at the current time. Most of Plantarc Bio's value examination focuses on studying past and present price action to predict the probability of Plantarc Bio's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Plantarc Bio's price. Additionally, you may evaluate how the addition of Plantarc Bio to your portfolios can decrease your overall portfolio volatility.